Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J S Langman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Fundamental & Clinical Pharmacology|August 14, 2003
Adverse effects of conventional non-steroidal anti-inflammatory drugs on the upper gastrointestinal tractMichael J S Langman
Heart (British Cardiac Society)|September 26, 2009
Psychotropic medication: curing illness or creating problems?Kate Jolly, Michael J S Langman
Drugs|April 4, 2002
NSAIDs and gastrointestinal cancer preventionKate Jolly, Kar K Cheng, Michael J S Langman
The Journal of Endocrinology|May 7, 2004
Targets of 17beta-oestradiol-induced apoptosis in colon cancer cells: a mechanism for the protective effects of hormone replacement therapy?Yan Qiu, Michael J S Langman, Margaret C Eggo
Experimental Cell Research|August 28, 2003
Protein kinase C inhibition induces DNA fragmentation in COLO 205 cells which is blocked by cysteine protease inhibition but not mediated through caspase-3Aurélia E Lewis, Benjamin C Y Wong, Michael J S Langman, et al.
Cellular Signalling|October 21, 2004
Protein kinase C delta is not activated by caspase-3 and its inhibition is sufficient to induce apoptosis in the colon cancer line, COLO 205Aurélia E Lewis, Radhika Susarla, Benjamin C Y Wong, et al.
British Journal of Clinical Pharmacology|November 18, 2009
Sudden death in patients receiving drugs tending to prolong the QT intervalKate Jolly, Michael D Gammage, Kar Keung Cheng, et al.
Scandinavian Journal of Gastroenterology|November 15, 2006
Antihypertensive medication and the risk of acute pancreatitis: the European case-control study on drug-induced acute pancreatitis (EDIP)Ingo A Eland, Anders Sundström, Giancarlo P Velo, et al.
The Journal of Rheumatology|July 26, 2002
Controversies in COX-2 selective inhibitionLee S Simon, Josef S Smolen, Steven B Abramson, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Fundamental & Clinical Pharmacology|August 14, 2003
Adverse effects of conventional non-steroidal anti-inflammatory drugs on the upper gastrointestinal tractMichael J S Langman
Heart (British Cardiac Society)|September 26, 2009
Psychotropic medication: curing illness or creating problems?Kate Jolly, Michael J S Langman
Drugs|April 4, 2002
NSAIDs and gastrointestinal cancer preventionKate Jolly, Kar K Cheng, Michael J S Langman
The Journal of Endocrinology|May 7, 2004
Targets of 17beta-oestradiol-induced apoptosis in colon cancer cells: a mechanism for the protective effects of hormone replacement therapy?Yan Qiu, Michael J S Langman, Margaret C Eggo
Experimental Cell Research|August 28, 2003
Protein kinase C inhibition induces DNA fragmentation in COLO 205 cells which is blocked by cysteine protease inhibition but not mediated through caspase-3Aurélia E Lewis, Benjamin C Y Wong, Michael J S Langman, et al.
Cellular Signalling|October 21, 2004
Protein kinase C delta is not activated by caspase-3 and its inhibition is sufficient to induce apoptosis in the colon cancer line, COLO 205Aurélia E Lewis, Radhika Susarla, Benjamin C Y Wong, et al.
British Journal of Clinical Pharmacology|November 18, 2009
Sudden death in patients receiving drugs tending to prolong the QT intervalKate Jolly, Michael D Gammage, Kar Keung Cheng, et al.
Scandinavian Journal of Gastroenterology|November 15, 2006
Antihypertensive medication and the risk of acute pancreatitis: the European case-control study on drug-induced acute pancreatitis (EDIP)Ingo A Eland, Anders Sundström, Giancarlo P Velo, et al.
The Journal of Rheumatology|July 26, 2002
Controversies in COX-2 selective inhibitionLee S Simon, Josef S Smolen, Steven B Abramson, et al.
Pageof 1